Covid-19 update: Omicron may be more dangerous for children

GSK’s top scientist to quit, become CEO of anti-ageing start-up

ProKidney signs SPAC merger deal with Social Capital Suvretta

Lilly and Evotec enter partnership for metabolic disease drug discovery

Merck-Ridgeback to supply courses of Covid-19 oral antiviral to UNICEF

Abbisko Therapeutics and Lilly partner to develop new molecules

Moderna eyes combined Covid-19, flu booster by 2023

AstraZeneca-Daiichi Sankyo’s breast cancer therapy gets FDA priority review

Covid-19 update: Fourth shot of vaccine can’t prevent Omicron infections

Health Canada grants authorisation to Pfizer’s Paxlovid for Covid-19

Medlab receives grant to develop NanoCelle nasal vaccine for Covid-19

GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business